1 Zaveri, NT (2006) Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 78, 2073–2080.
2 Cooper, R, Morre, DJ & Morre, DM (2005) Medicinal benefits of green tea, I: review of noncancer health benefits. J Altern Complement Med 11, 521–528.
3 Frei, B & Higdon, JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133, 3275S–3284S.
4 Bettuzi, S, Brausi, M, Rizzi, F, Castagnetti, G, Peracchia, G & Corti, A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66, 1234–1240.
5 Graham, HN (1992) Green tea composition, consumption, and polyphenol chemistry. Prev Med 21, 334–350.
6 Choi, JY, Park, CS, Kim, DJ, Cho, MH, Jin, BK, Pie, JE & Chung, WG (2002) Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin-3-gallate. Neurotoxicology 23, 367–374.
7 Ramassamy, C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545, 51–64.
8 Obregon, DF, Rezai-Zadeh, K, Bai, Y, et al. (2006) ADAM10 activation is required for green tea-EGCG-induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 281, 16419–16427.
9 Choi, YB, Kim, YL, Lee, KS, Kim, BS & Kim, DJ (2004) Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res 1019, 47–54.
10 Koh, SH, Lee, SM, Kim, HY, et al. (2006) The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neuro Lett 395, 103–107.
11 Lin, JK & Lin-Shiau, SY (2006) Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 50, 211–217.
12 Anderson, RA & Polansky, MM (2002) Tea enhances insulin activity. J Agric Food Chem 50, 7182–7186.
13 Tsuneki, H, Ishizuka, M, Terasawa, M, Wu, JB, Sasaoka, T & Kimura, L (2004) Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. Pharmacology 4, 18.
14 Adhami, VM, Malik, A, Zaman, N, Sarfaraz, S, Siddiqui, IA, Syed, DN, Afaq, F, Pasha, FS, Saleem, M & Mukhtar, H (2007) Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13, 1611–1619.
15 Kumar, N, Shibata, D, Helm, J, Coppola, D & Malafa, M (2007) Green tea polyphenols in the prevention of colon cancer. Front Biosci 12, 2309–2315.
16 Clark, J & You, M (2006) Chemoprevention of lung cancer by tea. Mol Nutr Food Res 50, 144–151.
17 Guo, Q, Zhao, B, Shen, S, Hoou, J, Hu, J & Xin, W (1999) ESR study on the structure–antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta 1427, 13–23.
18 Ahmed, S, Pakozdi, A & Koch, AE (2006) Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 54, 2393–2401.
19 Tedeshi, E, Suzuki, H & Megazzi, M (2002) Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann N Y Acad Sci 973, 435–437.
20 Unno, T, Sagesaka, YM & Kakuda, T (2005) Analysis of tea catechins in human plasma by high-performance liquid chromatography with solid-phase extraction. J Agric Food Chem 53, 9885–9889.
21 Henning, SM, Niu, Y, Liu, Y, Lee, NH, Hara, Y, Thames, GD, Minutti, RR, Carpenter, CL, Wang, H & Heber, D (2005) Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16, 610–616.
22 Lee, MJ, Maliakal, P, Chen, L, Meng, X, Bondoc, FY, Prabhu, S, Lambert, G, Mohr, S & Yang, CS (2002) Pharmacokinetics of tea catechins after ingestion of green tea and ( − )-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11, 1025–1032.
23 Chow, HH, Cai, Y, Alberts, DS, Hakim, I, Dorr, R, Shahi, F, Crowell, JA, Yang, CS & Hara, Y (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 10, 53–58.
24 Lee, MJ, Wang, ZY, Li, H, Chen, L, Sun, Y, Gobbo, S, Balentine, D & Yang, CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4, 393–399.
25 Van Amelsvoort, JMM, Hof, KHV, Mathot, JNJJ, Mulder, TPJ, Wiersma, A & Tijburg, LBM (2001) Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica 31, 891–901.
26 Yang, CS, Chen, L, Lee, MJ, Balentine, D, Chen Kuo, M & Schantz, SP (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7, 351–354.
27 Mata, ML, Lacueva, CA, Roura, E, Jáuregui, O, Escribano, E, Torre, C & Lamuela-Raventós, RM (2007) Absorption and pharmacokinetics of grapefruit flavanones in beagles. Br J Nutr 98, 86–92.
28 Swezey, RR, Aldridge, DE, LeValley, SE, Crowell, JA, Hara, Y & Green, CE (2003) Absorption, tissue distribution and elimination of 4-[H-3]-epigallocatechin gallate in beagle dogs. Int J Toxicol 22, 187–193.
29 Committee on Care and Use of Laboratory Animals (1985) Guide for the Care and Use of Laboratory Animals. Washington, DC: Institute of Laboratory Animals Resources, National Research Council.
30 Roura, E, Andres-Lacueva, C, Jauregui, O, Badia, E, Estruch, R, Izquierdo-Pulido, M & Lamuela-Raventos, RM (2005) Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma ( − )-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J Agric Food Chem 53, 6190–6194.
31 Urpí-Sardà, M, Jáuregui, O, Lamuela-Raventós, RM, Jaeger, W, Miksits, M, Covas, MI & Andrés-Lacueva, C (2005) Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77, 3149–3155.
32 Meng, X, Sang, S, Zhu, N, Lu, H, Sheng, S, Lee, MJ, Ho, CT & Yang, CS (2002) Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem Res Toxicol 15, 1042–1050.
33 Unno, T, Kondo, K, Itakura, H & Takeo, T (1996) Analysis of ( − )-epigallocatechin gallate in human serum obtained after ingesting green tea. Biosci Biotechnol Biochem 60, 2066–2068.
34 Kimura, M, Umegaki, K, Kasuya, Y, Sugisawa, A & Higuchi, M (2002) The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 56, 1186–1193.
35 Van het Hof, KH, Kivits, GA, Weststrate, JA & Tijburg, LB (1998) Bioavailability of catechins from tea: the effect of milk. Eur J Clin Nutr 52, 356–359.
36 Pietta, PG, Simonetti, P, Gardana, C, Brusamolino, A & Bombardelli, E (1998) Catechin metabolites after intake of green tea infusions. Biofactors 8, 111–118.
37 Crespy, V, Nancoz, N, Oliveira, M, Hau, J, Courtet-compondu, MC & Williamson, G (2004) Glucuronidation of the green tea catechins, ( − )-epigallocatechin-3-gallate and ( − )-epicatechin-3-gallate, by rat hepatic and intestinal microsomes. Free Radic Res 38, 1025–1031.
38 Feng, WY (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7, 755–809.
39 Morand, C, Crespy, V, Manach, C, Besson, C, Demigné, C & Rémésy, C (1998) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275, 212–219.
40 Koga, T & Meydani, M (2001) Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 73, 941–948.
41 Van Zanden, JJ, Van der Woude, H, Vaessen, J, Usta, M, Wortelboer, HM, Cnubben, N & Rietjens, I (2007) The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 74, 345–351..
42 Henning, SM, Niu, Y, Lee, NH, Thames, GD, Minutti, RR, Wang, H, Go, VL & Heber, D (2004) Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 80, 1558–1564.
43 Shargel, L & Yu, A (1999) Applied Biopharmaceutics and Pharmacokinetics, 4th ed. New York: Lange.
44 Chen, L, Lee, MJ, Li, H & Yang, CS (1997) Absorption, distribution, and elimination of the tea polyphenols in rats. Drug Metab Dispos 25, 1045–1050.